(+)-menthol
Star0
This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Generic Name
- (+)-menthol
- DrugBank Accession Number
- DB11344
- Background
Not Available
- Type
- Small Molecule
- Groups
- Experimental
- Structure
- Weight
- Average: 156.269
Monoisotopic: 156.151415264 - Chemical Formula
- C10H20O
- Synonyms
- (+)-(1S,2R,5S)-menthol
- (+)-(1S,3S,4R)-menthol
- (1S,2R,5S)-(+)-menthol
- (1S,2R,5S)-menthol
- D-menthol
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Associated Conditions
Indication Type Indication Combined Product Details Approval Level Age Group Patient Characteristics Dose Form Used in combination for symptomatic treatment of Joint pain ••• ••• Used in combination for symptomatic treatment of Muscle pain ••• ••• - Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs Browse all" title="About SNP Mediated Effects/ADRs" id="snp-actions-info" class="drug-info-popup" href="javascript:void(0);">
- Not Available
Interactions
- Drug Interactions Learn More" title="About Drug Interactions" id="structured-interactions-info" class="drug-info-popup" href="javascript:void(0);">
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Products
- Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.
- Active Moieties
Name Kind UNII CAS InChI Key Levomenthol unknown BZ1R15MTK7 2216-51-5 NOOLISFMXDJSKH-KXUCPTDWSA-N - Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Ay Bendito - Pain Relief (+)-menthol (4 g/100g) + Camphor (6 g/100g) Cream Topical AY BENDITO INTERNATIONAL, INC 2021-01-22 Not applicable US Ay Bendito - Thermoactive (+)-menthol (4 g/100g) + Camphor (6 g/100g) Cream Topical AY BENDITO INTERNATIONAL, INC 2021-01-22 Not applicable US Ay Bendito - Thermoactive (+)-menthol (4 g/100g) + Camphor (6 g/100g) Gel Topical AY BENDITO INTERNATIONAL, INC 2021-01-22 Not applicable US Balsang Pain Relief (+)-menthol (1.5 mg/100mL) + (S)-camphor (1.5 mg/100mL) + Methyl salicylate (5 mg/100mL) Solution Topical Genuine Drugs 2015-04-20 Not applicable US BlueStop Max (+)-menthol (10 mg/1g) + Lidocaine hydrochloride (40 mg/1g) Cream Topical Clavel Corporation 2023-01-10 Not applicable US
Categories
- Drug Categories
- Not Available
- Chemical TaxonomyProvided by Classyfire
- Description
- This compound belongs to the class of organic compounds known as menthane monoterpenoids. These are monoterpenoids with a structure based on the o-, m-, or p-menthane backbone. P-menthane consists of the cyclohexane ring with a methyl group and a (2-methyl)-propyl group at the 1 and 4 ring position, respectively. The o- and m- menthanes are much rarer, and presumably arise by alkyl migration of p-menthanes.
- Kingdom
- Organic compounds
- Super Class
- Lipids and lipid-like molecules
- Class
- Prenol lipids
- Sub Class
- Monoterpenoids
- Direct Parent
- Menthane monoterpenoids
- Alternative Parents
- Monocyclic monoterpenoids / Cyclohexanols / Cyclic alcohols and derivatives / Hydrocarbon derivatives
- Substituents
- Alcohol / Aliphatic homomonocyclic compound / Cyclic alcohol / Cyclohexanol / Hydrocarbon derivative / Monocyclic monoterpenoid / Organic oxygen compound / Organooxygen compound / P-menthane monoterpenoid / Secondary alcohol
- Molecular Framework
- Aliphatic homomonocyclic compounds
- External Descriptors
- p-menthan-3-ol (CHEBI:76306)
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- C6B1OE8P3W
- CAS number
- 15356-60-2
- InChI Key
- NOOLISFMXDJSKH-AEJSXWLSSA-N
- InChI
- InChI=1S/C10H20O/c1-7(2)9-5-4-8(3)6-10(9)11/h7-11H,4-6H2,1-3H3/t8-,9+,10-/m0/s1
- IUPAC Name
- (1S,2R,5S)-5-methyl-2-(propan-2-yl)cyclohexan-1-ol
- SMILES
- CC(C)[C@H]1CC[C@H](C)C[C@@H]1O
References
- General References
- Not Available
- External Links
- ChemSpider
- 145189
- 1648123
- ChEBI
- 76306
- ChEMBL
- CHEMBL2106989
- ZINC
- ZINC000000967511
Clinical Trials
- Clinical Trials Learn More" title="About Clinical Trials" id="clinical-trials-info" class="drug-info-popup" href="javascript:void(0);">
Phase Status Purpose Conditions Count
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Gel Topical Solution Topical Cream Topical Patch Topical - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source Water Solubility 0.558 mg/mL ALOGPS logP 2.68 ALOGPS logP 2.66 Chemaxon logS -2.4 ALOGPS pKa (Strongest Acidic) 19.55 Chemaxon pKa (Strongest Basic) -0.81 Chemaxon Physiological Charge 0 Chemaxon Hydrogen Acceptor Count 1 Chemaxon Hydrogen Donor Count 1 Chemaxon Polar Surface Area 20.23 Å2 Chemaxon Rotatable Bond Count 1 Chemaxon Refractivity 47.45 m3·mol-1 Chemaxon Polarizability 19.68 Å3 Chemaxon Number of Rings 1 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter No Chemaxon Veber's Rule Yes Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
Spectrum Spectrum Type Splash Key Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS splash10-0002-9400000000-1725adcedf912eaa92fe Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS splash10-0a4i-0900000000-b6377df362903ebb5f82 Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS splash10-0a4i-0900000000-47694ad7d401825e6e66 Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS splash10-0541-9200000000-1080fe48e386942d59a2 Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS splash10-00di-1900000000-d727078dd6b1afa92c3d Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS splash10-0036-9000000000-7c3553f8ea4ed276a44e Predicted 1H NMR Spectrum 1D NMR Not Applicable Predicted 13C NMR Spectrum 1D NMR Not Applicable - Chromatographic Properties
Collision Cross Sections (CCS)
Adduct CCS Value (Å2) Source type Source [M-H]- 137.3093104 predictedDarkChem Lite v0.1.0 [M-H]- 137.0062104 predictedDarkChem Lite v0.1.0 [M-H]- 146.19456 predictedDeepCCS 1.0 (2019) [M+H]+ 137.7690104 predictedDarkChem Lite v0.1.0 [M+H]+ 137.9335104 predictedDarkChem Lite v0.1.0 [M+H]+ 148.64532 predictedDeepCCS 1.0 (2019) [M+Na]+ 137.5408104 predictedDarkChem Lite v0.1.0 [M+Na]+ 157.02116 predictedDeepCCS 1.0 (2019)
Drug created at December 03, 2015 16:52 / Updated at September 28, 2021 21:54